Pancreatic cancer: terra incognita in modern gastroenterology
PDF (Русский)
DOCX

Keywords

pancreatic cancer, classification, risk factors, clinical features, diagnostics, treatment

How to Cite

Tsimmerman, Y. S. (2016). Pancreatic cancer: terra incognita in modern gastroenterology. Herald of Pancreatic Club, 32(3), 8-16. https://doi.org/10.33149/vkp.2016.03.02

Abstract views: 35
PDF Downloads: 154 PDF Downloads: 43

Abstract

The author presents definition of pancreatic cancer (PC), epidemiological data on its prevalence, risk factors (chronic pancreatitis, viral hepatitis B, smoking, etc.), and clinical symptoms. Modern laboratory and instrumental differential diagnostic methods are discussed. Morphological classification and stages of the neoplastic process are considered with special reference to the methods of its surgical treatment and adjuvant therapy.

https://doi.org/10.33149/vkp.2016.03.02
PDF (Русский)
DOCX

References

1. Василенко В. Х. О диагностике рака поджелудочной железы / В. Х. Василенко, З. А. Лемешко // Клин. мед. – 1984. – 10. – С. 131–137.
2. Гарин A. M. Злокачественные опухоли пищеваритель¬ной системы / A. M. Гарин, И. С. Базин. – М., 2003.
3. Губергриц Н. Б. Клиническая панкреатология / Н. Б. Губергриц, Т. Н. Христич. – До¬нецк, 2000.
4. Губергриц Н. Б. Практическая панкреатология / Н. Б. Губергриц, С. В. Скопиченко. – Донецк, 2007.
5. Губергриц Н. Б. Хронический панкреатит как предраковое заболевание / Н. Б. Губергриц, О. А. Голубова // Вестник клуба панкреа¬тологов. – 2009. – № 4. – С. 36–41.
6. Калинин А. В. Исследование опухолевых маркеров / А. В. Калинин // Руковод¬ство по гастроэнтерологии / Под ред. Ф. И. Комарова, С. И. Рапопорта. – М., 2010. – С. 125–129.
7. Капранов Н. И. Муковисцидоз / Н. И. Капранов // Российск. журн. гастроэнтерол., гепатол. и колопроктол. – 2000. – № 1. – С. 62–66.
8. Кубышкин В. А. Рак поджелудочной железы / В. А. Кубышкин, В. А. Вишневский. – М., 2003.
9. Маев И. В. Эпидемиологические и молекулярно-генетические аспек¬ты ассоциации хронического панкреатита и рака поджелудочной железы / И. В. Маев // Экспер. и клин. гастроэнтерол. – 2005. – № 2. – С. 12–17.
10. «Панкреатический омнибус» (наследственный панкреатит) / Т. Н. Христич, Т. Е. Кендзерская, В. П. Пишак, Н. Б. Губергриц // Вестник клуба панкреатологов. – 2009. – № 3. – С. 40–47.
11. Патютко Ю. И. Диагностика и хирургическое лечение рака поджелудочной железы / Ю. И. Патютко, А. Г. Котельников // Российск. журн. гастроэнтерол., гепатол. и колопроктол. – 1997. – № 5. – С. 67–72.
12. Попович А. Ю. Рак поджелудочной железы / А. Ю. Попович // Вестник клуба панкреатологов. – 2009. – № 3. – С. 31–39.
13. Применение режима трехмерной реконструкции ультразвукового изображения в диф¬ференциальной диагностике заболеваний головки поджелудочной железы / И. В. Maeв, A. A. Рязанцев, E. C. Вьючнова // Клин. мед. – 2009. – № 10. – С. 67–72.
14. Путов Н. В. Рак поджелудочной железы / Н. В. Путов, Н. Н. Артемьев, Н. Ю. Коханенко. – М., 2005.
15. Рак поджелудочной железы: некоторые вопросы диагностики и лече¬ния / А. П. Кошель, С. С. Клоков, Е. Б. Миронова, Н. В. Севастьянова // Вестник клуба панкреатологов. – 2010. – № 2. – С. 19–22.
16. Скуя Н. А. Заболевания поджелудочной железы / Н. А. Скуя. – М., 1986.
17. Хронический панкреатит и рак поджелудочной железы / Л. В. Лазебник, Л. В. Винокурова, Н. И. Яшина [и др.] // Вестник клуба панкреа¬тологов. – 2014. – № 1. – С. 39–44.
18. Циммерман Я. С. Лабораторная и инструментальная диагностика заболеваний поджелудочной железы / Я. С. Циммерман // Клин. мед. – 2011. – № 6. – С. 9–16.
19. Циммерман Я. С. Хронический панкреатит: современное состоя¬ние проблемы / Я. С. Циммерман // Клин. мед. – 2007. – № 1. – С. 16–20; Клин. мед. – 2007. – № 2. – С. 9–14.
20. Adjuvant 5-fluoro-uracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials / J. P. Neoptolemos, D. D. Stocken, S. C. Tudur [et al.] // Brit. J. Cancer. – 2009. – Vol. 100. – P. 246–250.
21. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer : a randomized con¬trolled trial / J. Neoptolemos, J. Dunn, D. Stocken [et al.] // Lancet. – 2001. – Vol. 358. – P. 1576–1585.
22. Alcohol, tobacco and coffee consumption and the risk of pancreatic cancer: results from the Canadian Enhanced – Surveillance System case-control project / P. J. Villeneuve, К. С. Johnson, A. J. Hanley, Y. Мао // Canadian Cancer Registries Epidemiology Research Group // Eur. J. Cancer Prev. – 2000. – Vol. 9. – P. 49–58.
23. Arterial resection during pancreatectomy for pancreatic cancer : a systematic review and meta-analysis / N. Mollberg, N. N. Rahbari, M. Koch [et al.] // Ann. Surg. – 2011. – Vol. 254. – P. 882–893.
24. Association of cathepsin B-gene polymorphisms with tropical calcific pancreatitis / S. Mahurkar, M. M. Idris, D. N. Reddy [et al.] // Gut. – 2006. – 55. – C. 1270–1275.
25. Bardeesy N., DePinho R. A. Pancreatic cancer biology and genetics / N. Bardeesy, R. A. DePinho // Nat. Rev. Cancer. – 2002. – Vol. 2, No 12. – P. 897–909.
26. CA 19-9 in potentially resectable pancreatic cancer. Perspective to adjust surgical and perioperative therapy / W. Hartwig, О. StrobeI, U. Hinz [et al.] // Ann. Surg. Oncol. – 2013. – Vol. 20. – P. 2188–2196.
27. Cancer statistics (2007) / A. Jemal, R. Siegel, E. Ward [et al.] // CA Cancer. J. Clin. – 2007. – Vol. 57, No 1. – P. 131–137.
28. CD10+ pancreatic stellate cells enhance the progression of pancreatic cancer / N. Ikenaga, K. Ohuchida, K. Mizumoto [et al.] // Gastroenterology. – 2010. – Vol. 139. – P. 1041–1051.
29. Chang K. J. State of the art lecture: endoscopic ultrasound (EUS) and FNA in pancreatico-biliary tumors / K. J. Chang // Endoscopy. – 2006. – Vol. 38, Suppl. 1. – P. 556–560.
30. Chua T. C. Extended pancreaticoduodenectomy with vascu¬lar resection for pancreatic cancer : a systematic review / T. C. Chua, A. Saxena // J. Gastroente¬rol. Surg. – 2010. – Vol. 14. – P. 1442–1452.
31. Clinical and genetic characterization of patients with hereditary pancreatitis and mutations in the cationic trypsinogen gene / N. Howes, M. M. Lerch, W. Greenhalf [et al.] // Am. J. Med. – 2001. – Vol. 111, No 8. – P. 622–626.
32. Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent / S. C. Mayo, H. Nathan, J. L. Cameron [et al.] // Cancer. – 2012. – Vol. 118. – P. 2674–2681.
33. Definition of a standard lymph- adenectomy in surgery for pancreatic ductal adenocarcinoma : a con¬sensus statement by the International Study Group on Pancreatic Sur¬gery (ISGPS) / J. A. Тоl, D. J. Gouma, C. Bassi [et al.] // Surgery. – 2014. – Vol. 156, No 3. – P. 591–600.
34. Desmoplastic reaction of pancreatic cancer: role of pancreatic stellate cells / M. V. Apte, S. Park, A. Phillips [et al.] // Pancreas. – 2004. – Vol. 29. – P. 179–187.
35. Diseases of the pancreas / M. W. Büchler, W. Uhl, P. Malfertheiner, M. G. Sarr. – Basel-Freiburg-Paris: Karger, 2004.
36. Ductal neoplasia of the pancreas nosologic, clinicopathologic and biologic aspects / N. Y. Adsay, О. Basturk, J. D. Cheng [et al.] // Semin. Radiat. Oncol. – 2005. – Vol. 15, No 4. – P. 254–264.
37. Endoscopic ultrasound for vascular invasion in the staging of cancer of the head of pancreas. A blind reevalution of videotopes / O. Keriven-Souquet, J. C. Souquet, T. Ponchon [et al.] // Gastrointestinal Endoscopy. – 2000. – Vol. 52, No 4. – P. 158–162.
38. EUS-FNA mutational analysis in differentiating autoimmune pancreatitis and pancreatic cancer / A. Khalid, J. Dewitt, N. P. Ohori [et al.] // Pancreatology. – 2011. – Vol. 11. – P. 482–486.
39. Exocrine pancreas cancer: The European Pancreatic Can¬cer – Research Cooperative (EPS-RC) / T. M. Gress, J. P. Neoptolemos, N. R. Lemoine [et al.]. – Hannover; Felsenstein, 2005.
40. Farrow В. Inflammation and the development of pancreatic cancer / В. Farrow, В. М. Evers // Surg. Oncol. – 2002. – Vol. 10. – P. 153–169.
41. Genetic and epigenetic alterations in pancreatic cancerogenesis / Y. Delpu, N. Hanoun, H. Lulka [et al.] // Curr. Genomics. – 2011. – Vol. 12. – P. 15–24.
42. Hartwig W. Pancreatic cancer: current options for diagnosis, staging and therapeutic management / W. Hartwig, M. W. Büchler // Gastrointest. Tumors. – 2014. – Vol. 1. – P. 41–52.
43. Heinemann V. Meta-analysis of randomized trials : evaluation of benefit from gemcitabine-based combination chemothe¬rapy applied in advanced pancreatic cancer / V. Heinemann, S. Boeck, A. Hinke // BMC Cancer. – 2008. – Vol. 8. – P. 82–85.
44. Hepatitis В virus status and risk of pancreatic ductal adenocarcinoma / Q. Ben, Z. Li, C. Liu [et al.] // Pancreas. – 2012. – Vol. 41, No 3. – P. 435–440.
45. Identification of pancreatic stem cells / C. Li, D. G. Heidt, P. Dalerba [et al.] // Cancer Res. – 2007. – Vol. 67. – P. 1030–1037.
46. Increased incidence of cancer in chronic pancreatitis / G. Rocca, Е. Gaja, R. Luliano [et al.] // J. Clin. Gastroenterol. – 1987. – № 9. – C. 175–179.
47. Isaji S. Classification of pancreatic cancer: comparison of Japanese and ULCC classifications / S. Isaji, Y. Kawarada, S. Uemoto // Pancreas. – 2004. – Vol. 28. – P. 231–234.
48. Johnson P. Т. Pancreatic carcinoma versus chronic pancreatitis. – C. Dynamic MR imaging / P. Т. Johnson, E. K. Outwater // Radiology. – 1999. – Vol. 212, No 1. – P. 213–218.
49. Krejs G. J. Pancreatic cancer epidemiology and risk factors / G. J. Krejs // Dig. Dis. – 2010. – Vol. 28, No 2. – P. 355–358.
50. Lilley M. The hereditary spectrum of pancreatic cancer : the Edmonton experience / M. Lilley, D. Gilchrist // Can. J. Gastroenterol. – 2004. – Vol. 18, No 1. – P. 17–21.
51. Low sensetivity of the K-ras polymerase chain reaction for diagnosing pancreatic cancer from pancreatic juice and bile : a multicenter prospective trial / L. Trumper, M. Menges, H. Daus [et al.] // J. Clin. Oncol. – 2002. – 20. – P. 4331–4337.
52. McKay C. J. Chronic inflammation and pan¬creatic cancer / C. J. McKay, P. Glen, D. C. McMillan // Clin. Gastroenterology. – 2008. – Vol. 22, No 1. – P. 65–71.
53. Meta-analysis of ran¬domized adjuvant therapy trials for pancreatic cancer / D. D. Stocken, M. W. Büchler, C. Dervenis [et al.] // Brit. J. Can¬cer. – 2005. – Vol. 92. – P. 1372–1381.
54. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis / M. Bloomston, W. L. Frankel, F. Petrocca [et al.] // JAMA. – 2007. – Vol. 297. – P. 1901-1908.
55. Molecular pathology of pancreatic cancer / R. H. Hruban, С. Lacobuzio-Donobue, R. E. Wilentz [et al.] // Cancer J. (Sudbury Mass). – 2001. – Vol. 7, No 4. – P. 251–258.
56. Most human carcinomas of the exocrine pancreas contain mutant K-ras genes / C. Almoguera, D. Shibata, K. Forrester [et al.] // Cell. – 1988. – Vol. 53. – C. 549–544.
57. p16 (INK4a) alterations in chronic pancreatitis-indicator for high-risk lesions for pancreatic cancer / В. Gerdes, A. Ramaswamy, М. Kersting [et al.] // Surgery. – 2001. – Vol. 129. – P. 490–497.
58. p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions / M. S. Redston, C. Caldas, A. B. Seymour [et al.] // Cancer Res. – 1994. – Vol. 54. – C. 3025–3033.
59. Pancreatic adenocarcinoma tumor grade determination using contrast – enhanced magnetic resonance imaging / Т. С. Lauenstein, D. R. Martin, J. M. Sarmiento [et al.] // Pancreas. – 2010. – Vol. 39, No 1. – P. 71–75.
60. Pancreatic cancer in chronic pancreatitis. Aetiology incidence and early detection / S. Raimondi, A. B. Lowenfels, A. M. Morselli-Labate [et al.] // Clin. Gastroenterol. – 2010. – Vol. 24, No 3. – P. 349–358.
61. Pancreatic cancer: clinical significance of biomarkers / K. Ohuchida, Т. Ohtsuka, K. Mizumoto [et al.] // Gastrointest. Tumors. – 2014. – Vol. 1. – P. 33–40.
62. Pancreatic stellate cells – role in pancreas cancer / M. G. Bachem, S. Zhou, К. Buck [et al.] // Langenbecks Arch. Surg. – 2008. – Vol. 393. – P. 891–900.
63. Pancreatitis and the risk of pancreatic cancer / A. B. Lowenfels, P. Maisonneuve, G. Cavallini [et al.] // N. Engl. J. Med. – 1993. – Vol. 328. – P. 1433–1437.
64. Phase III randomized comparison of gemcitabine plus capecitabine in patients with advanced pancreatic cancer / D. Cunningham, I. Chau, D. D. Stocken [et al.] // J. Clin. Oncol. – 2009. – Vol. 27. – P. 5513–5518.
65. Preoperative tissue diagno¬sis for tumours of the pancreas / W. Hartwig, L. Schneider, M. K. Diener [et al.] // Brit. J. Surg. – 2009. – Vol. 96. – P. 5–20.
66. A prospective pancreatographic study of the prevalence of pancreatic carcinoma in patients with diabetes melitus / Y. Ogawa, М. Tanaka, К. Inoue [et al.] // Cancer. – 2002. – Vol. 94, No 9. – P. 2344–2349.
67. Rieder H. Familial pancreatic cancer / H. Rieder, D. K. Bartsch // Fam. Cancer. – 2004. – Vol. 3, No 1. – P. 69–74.
68. S100P is an early developmental marker of pancreatic carcinogenesis / K. Ohuchida, K. Mizumoto, T. Egami [et al.] // Clin. Cancer Res. – 2006. – Vol. 12. – P. 5411–5416.
69. S100P promotes pancreatic cancer growth survival, and invasion / Т. Arumugam, D. M. Simeone, K. Van Golen, C. D. Logsdon // Clin. Cancer Res. – 2005. – Vol. 11. – P. 5356–5364.
70. The prognostic and predictive value of serum CA 19-9 in pancreatic cancer / J. L. Humphris, D. K. Chang, A. L. Johns [et al.] // Ann. Oncol. – 2012. – Vol. 23. – P. 1713–1722.
71. The race from chronic pancreatitis to pancreatic cancer / G. M. Cavastro, С. Giuseppe, A. Nouvenne [et al.] // JOP. – 2003. – Vol. 4, No 5. – P. 165–168.
72. TNM classification of Malignant Tumors / Eds. L. H. Sobin, M. K. Gospodarowicz, C. Wittekind. – N.Y. : Wiley-Blackwell, 2009.